|
|
|
Volumn 119, Issue 1236, 2006, Pages
|
|
PHARMAC and EpiPen for anaphylaxis.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADRENALIN;
BETA ADRENERGIC RECEPTOR STIMULATING AGENT;
ADULT;
ANAPHYLAXIS;
ATTITUDE TO HEALTH;
CHILD;
COST BENEFIT ANALYSIS;
DRUG CONTROL;
DRUG SELF ADMINISTRATION;
ECONOMICS;
HUMAN;
INSTRUMENTATION;
METHODOLOGY;
NEW ZEALAND;
NOTE;
PUBLIC HEALTH;
ADRENERGIC BETA-AGONISTS;
ADULT;
ANAPHYLAXIS;
CHILD;
COST-BENEFIT ANALYSIS;
DRUG AND NARCOTIC CONTROL;
EPINEPHRINE;
HEALTH KNOWLEDGE, ATTITUDES, PRACTICE;
HUMANS;
NATIONAL HEALTH PROGRAMS;
NEW ZEALAND;
SELF ADMINISTRATION;
|
|
EID: 33746199840
PISSN: None
EISSN: 11758716
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (3)
|
|
References (0)
|
